US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Fractyl Health

1.61

-0.5300-24.77%

Post-market: 1.750.1400+8.70%19:59 EDT

Volume:6.21M

Turnover:12.90M

Market Cap:78.85M

PE:-0.87

High:1.98

Open:1.75

Low:1.55

Close:2.14

Loading ...

Overview Company News Filings

Fractyl Health Announces Promising Preclinical Results for RJVA-001, a Novel Gene Therapy for Diabetes and Obesity

Fractyl Health’s Earnings Call: Clinical Progress Amid Financial Concerns

BRIEF-Fractyl Health Announces First Quarter 2025 Financial Results And Business Updates

Fractyl Health Q1 EPS $(0.49) Beats $(0.50) Estimate

Fractyl Health Inc. Reports Q1 2025 Net Loss of $23.7 Million, Up from $3.3 Million in 2024, Amid Increased Operating Expenses and Fluctuations in Fair Value of Notes and Warrants

Fractyl Health Inc: Cash Position Will Fund Operations Into Q4 of 2025

THOMSON REUTERS

Fractyl Health to Report First Quarter 2025 Financial Results and Provide Business Updates on May 13, 2025, and Will Participate in an Upcoming Investor Conference

THOMSON REUTERS

Fractyl Health to Present Compelling Preclinical Data from its Rejuva® Single-Administration Smart GLP-1 Pancreatic Gene Therapy Platform at the American Society of Gene and Cell Therapy (ASGCT) 2025 Annual Meeting

Discover Fractyl Health And 2 More Promising Penny Stocks

Simply Wall St.

Fractyl Health Initiated at Buy by Canaccord Genuity

Fractyl Health, Inc. (GUTS): Insider Were Buying In Q1 2025

Fractyl Health Shares up 1.7% on Early-Stage Data From Weight Management Device Study

THOMSON REUTERS

BUZZ-Fractyl Health gains on early data from weight management device trial

Fractyl Health Inc - Midpoint Analysis of Remain-1 Pivotal Study Expected in Q3 2025

THOMSON REUTERS

Fractyl Health Inc - Additional Reveal-1 Patient Follow-up Data Expected in Q2 2025

THOMSON REUTERS

Fractyl Health Reports Positive Early Data Showing Revita® Has Potential to Prevent Weight Regain After Glp-1 Discontinuation

THOMSON REUTERS

Fractyl Health Inc - No Safety or Tolerability Concerns Reported in 15 Patients Treated

THOMSON REUTERS

Fractyl Health Reports Positive Early Data Showing Revita® Has Potential to Prevent Weight Regain After GLP-1 Discontinuation

Fractyl Health’s Earnings Call: Progress Amid Challenges

Spotlight On Fractyl Health And Two Other Intriguing Penny Stocks

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/GUTS/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GUTS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GUTS\",,,,,undefined,":{"symbol":"GUTS","market":"US","secType":"STK","nameCN":"Fractyl Health","latestPrice":1.61,"timestamp":1750708800000,"preClose":2.14,"halted":0,"volume":6209821,"hourTrading":{"tag":"盘后","latestPrice":1.75,"preClose":1.61,"latestTime":"19:59 EDT","volume":31809,"amount":52780.0052,"timestamp":1750723194336},"delay":0,"floatShares":18161148,"shares":48976636,"eps":-1.843961,"marketStatus":"Not Yet Opened","change":-0.53,"latestTime":"06-23 16:00:00 EDT","open":1.75,"high":1.98,"low":1.55,"amount":12899713.325796401,"amplitude":0.200935,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.843961,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750752000000},"marketStatusCode":0,"adr":0,"listingDate":1706850000000,"exchange":"NASDAQ","adjPreClose":2.14,"preHourTrading":{"tag":"盘前","latestPrice":1.77,"preClose":2.14,"latestTime":"09:29 EDT","volume":1841067,"amount":4051484.4429792003,"timestamp":1750685391433},"postHourTrading":{"tag":"盘后","latestPrice":1.75,"preClose":1.61,"latestTime":"19:59 EDT","volume":31809,"amount":52780.0052,"timestamp":1750723194336},"volumeRatio":24.431685},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GUTS\",,,,,undefined,":{"symbol":"GUTS","floatShares":18161148,"roa":"-49.05%","roe":"-196.81%","lyrEps":-1.617559,"volumeRatio":24.431685,"shares":48976636,"dividePrice":0,"high":1.98,"amplitude":0.200935,"preClose":2.14,"low":1.55,"week52Low":0.873,"pbRate":"12.37","psRate":"1314.21","week52High":5.3432,"institutionHeld":0,"latestPrice":1.61,"eps":-1.843961,"divideRate":0,"volume":6209821,"delay":0,"ttmEps":-1.843961,"open":1.75,"prevYearClose":2.06,"prevWeekClose":2.14,"prevMonthClose":1.9,"prevQuarterClose":1.19,"fiveDayClose":2.06,"twentyDayClose":1.755,"sixtyDayClose":1.27},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GUTS\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2536307052","title":"Fractyl Health Announces Promising Preclinical Results for RJVA-001, a Novel Gene Therapy for Diabetes and Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2536307052","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536307052?lang=en_us&edition=fundamental","pubTime":"2025-05-17 19:15","pubTimestamp":1747480522,"startTime":"0","endTime":"0","summary":"Fractyl Health Inc., a company focused on innovative metabolic therapeutics, has presented promising preclinical data from their Rejuva smart GLP-1 gene therapy platform at the ASGCT 2025 Annual Meeting. The research highlights the potential of RJVA-001, a gene therapy designed to restore natural physiologic signaling in the pancreas, offering durable disease modification in diabetes and obesity. This approach aims to achieve these effects without the high systemic drug exposure associated with current GLP-1 therapies, thus minimizing side effects. Preclinical models have demonstrated RJVA-001's superior potency, durability, and convenience, along with a potentially improved tolerability profile. The therapy showed targeted delivery and strong efficacy in animal models, and no toxicity was observed. Fractyl Health is advancing toward first-in-human studies, with a clinical trial application expected by June 2025.Disclaimer: This news brief was created by Public Technologies  using gene","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250517:nNDL3LNX1t:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4112","IE00B64PRP62.GBP","NDAQ","GUTS","IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4082","LU2210150020.SGD","LU2210149790.SGD","LU2095319765.USD","BK4588","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2535387985","title":"Fractyl Health’s Earnings Call: Clinical Progress Amid Financial Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=2535387985","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535387985?lang=en_us&edition=fundamental","pubTime":"2025-05-16 10:22","pubTimestamp":1747362129,"startTime":"0","endTime":"0","summary":"Fractyl Health, Inc. (($GUTS)) has held its Q1 earnings call. Read on for the main highlights of the call. Fractyl Health, Inc. recently held its e...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fractyl-healths-earnings-call-clinical-progress-amid-financial-concerns?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fractyl-healths-earnings-call-clinical-progress-amid-financial-concerns?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GUTS","PRGS"],"gpt_icon":0},{"id":"2535152087","title":"BRIEF-Fractyl Health Announces First Quarter 2025 Financial Results And Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2535152087","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535152087?lang=en_us&edition=fundamental","pubTime":"2025-05-14 04:41","pubTimestamp":1747168895,"startTime":"0","endTime":"0","summary":"BRIEF-Fractyl Health Announces First Quarter 2025 Financial Results And Business UpdatesMay 13 (Reuters) - Fractyl Health Inc GUTS.O:FRACTYL HEALTH ANNOUNCES FIRST QUARTER 2025 FINANCIAL RESULTS AND B","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nTUA9TWMVY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GUTS","BK4082"],"gpt_icon":0},{"id":"2535823660","title":"Fractyl Health Q1 EPS $(0.49) Beats $(0.50) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2535823660","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535823660?lang=en_us&edition=fundamental","pubTime":"2025-05-14 04:23","pubTimestamp":1747167785,"startTime":"0","endTime":"0","summary":"Fractyl Health (NASDAQ:GUTS) reported quarterly losses of $(0.49) per share which beat the analyst consensus estimate of $(0.50) by 2 percent. This is a 188.24 percent decrease over losses of $(0.17) per share from the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45390944/fractyl-health-q1-eps-0-49-beats-0-50-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GUTS"],"gpt_icon":0},{"id":"2535084844","title":"Fractyl Health Inc. Reports Q1 2025 Net Loss of $23.7 Million, Up from $3.3 Million in 2024, Amid Increased Operating Expenses and Fluctuations in Fair Value of Notes and Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2535084844","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535084844?lang=en_us&edition=fundamental","pubTime":"2025-05-14 04:05","pubTimestamp":1747166738,"startTime":"0","endTime":"0","summary":"Fractyl Health Inc. Reports Q1 2025 Net Loss of $23.7 Million, Up from $3.3 Million in 2024, Amid Increased Operating Expenses and Fluctuations in Fair Value of Notes and Warrants. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fractyl Health Inc. published the original content used to generate this news brief via GlobeNewswire  on May 13, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nNDL9sBhGj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","GUTS"],"gpt_icon":0},{"id":"2535822790","title":"Fractyl Health Inc: Cash Position Will Fund Operations Into Q4 of 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2535822790","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535822790?lang=en_us&edition=fundamental","pubTime":"2025-05-14 04:05","pubTimestamp":1747166703,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nTUA9TWMVY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","GUTS"],"gpt_icon":0},{"id":"2533168503","title":"Fractyl Health to Report First Quarter 2025 Financial Results and Provide Business Updates on May 13, 2025, and Will Participate in an Upcoming Investor Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2533168503","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533168503?lang=en_us&edition=fundamental","pubTime":"2025-05-06 19:00","pubTimestamp":1746529204,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250506:nTUA4FG3VT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","GUTS"],"gpt_icon":0},{"id":"2531942392","title":"Fractyl Health to Present Compelling Preclinical Data from its Rejuva® Single-Administration Smart GLP-1 Pancreatic Gene Therapy Platform at the American Society of Gene and Cell Therapy (ASGCT) 2025 Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2531942392","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531942392?lang=en_us&edition=fundamental","pubTime":"2025-04-29 04:30","pubTimestamp":1745872200,"startTime":"0","endTime":"0","summary":"BURLINGTON, Mass., April 28, 2025  -- Fractyl Health, Inc.  , a metabolic therapeutics company focused on pattern-breaking approaches to treat the root causes of obesity and type 2 diabetes , today announced that it will deliver an oral presentation of compelling preclinical data from its Rejuva single-administration Smart GLP-1 pancreatic gene therapy platform at the American Society of Gene and Cell Therapy  2025 Annual Meeting, taking place May 13-17, 2025, in New Orleans, Louisiana.Title: Endoscopic Ultrasound-Guided Delivery of Human Glucagon-like Peptide-1 Pancreatic Gene Therapy: Safety and Feasibility in a Porcine ModelSession: AAV Preclinical and Proof-of-Concept StudiesDate and Time: Saturday, May 17, 2025, 9:15 a.m. – 9:30 a.m. CTLocation: NOLA Theater A. Investor Contact Brian Luque, Head of Investor Relations and Corporate DevelopmentIR@fractyl.com, 951.206.1200","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fractyl-health-present-compelling-preclinical-203000689.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CTA","GLP","BK4117","AFG","BK4144","BK4082","BK4107","BK4590","GUTS"],"gpt_icon":0},{"id":"2529309561","title":"Discover Fractyl Health And 2 More Promising Penny Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2529309561","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529309561?lang=en_us&edition=fundamental","pubTime":"2025-04-22 20:05","pubTimestamp":1745323516,"startTime":"0","endTime":"0","summary":"Over the last 7 days, the United States market has dropped 4.4%, yet earnings are forecast to grow by 13% annually. For those looking to invest in smaller or newer companies, penny stocks can still offer surprising value despite their somewhat outdated name. With solid financial foundations, these stocks have the potential to outperform while offering greater stability, making them intriguing options for investors seeking under-the-radar opportunities with long-term potential.Click here to see the full list of 789 stocks from our US Penny Stocks screener.Overview: Fractyl Health, Inc. is a metabolic therapeutics company focused on developing treatments for type 2 diabetes and obesity, with a market cap of approximately $59.68 million.Overview: 4D Molecular Therapeutics, Inc. is a late-stage biotechnology company focused on developing adeno-associated virus vectors using its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution, operating in the Netherlands and t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/discover-fractyl-health-2-more-120516764.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4509","BABB","TSHA","BK4021","LU2360107671.USD","GUTS","LU0106831901.USD","BK4563","CINT","FDMT","LU1861220207.SGD","LU1791807156.HKD","LU1861217088.USD","BK4585","BK4505","BK4023","BK4588","SB","BK4082","DFS","TUYA","LU1668664300.SGD","BK4166","BK4526","BK4134","BK4209","BK4139"],"gpt_icon":0},{"id":"2527415085","title":"Fractyl Health Initiated at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2527415085","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527415085?lang=en_us&edition=fundamental","pubTime":"2025-04-15 20:41","pubTimestamp":1744720860,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GUTS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 15, 2025 08:41 ET (12:41 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","GUTS"],"gpt_icon":0},{"id":"2524329443","title":"Fractyl Health, Inc. (GUTS): Insider Were Buying In Q1 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2524329443","media":"Insider Monkey","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524329443?lang=en_us&edition=fundamental","pubTime":"2025-04-03 03:34","pubTimestamp":1743622489,"startTime":"0","endTime":"0","summary":"We recently published a list of 10 Micro-Cap Stocks Insiders Were Buying In Q1 2025. In this article, we are going to take a look at where Fractyl Health, Inc.  stands against other micro-cap stocks insiders were buying in Q1 2025.The White House announced Tuesday that Trump’s tariffs would take effect immediately after being unveiled on Wednesday. In anticipation of these “reciprocal tariffs,” which will apply to all countries, the stock market reacted. By Tuesday morning, the broader market index and Nasdaq Composite dropped by about 0.2%, while blue-chip companies lost 0.06%.Amid ongoing market uncertainty, insider trading often comes under the spotlight. Executive stock purchases can signal optimism, but sales may reflect personal financial decisions or a need to diversify investments. To maintain transparency, executives typically follow pre-arranged strategies, like 10b5-1 plans. While insider trading can offer valuable information, it’s important to evaluate it in the broader co","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fractyl-health-inc-guts-insider-193449444.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["GUTS","BK4082"],"gpt_icon":0},{"id":"2524146031","title":"Fractyl Health Shares up 1.7% on Early-Stage Data From Weight Management Device Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2524146031","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524146031?lang=en_us&edition=fundamental","pubTime":"2025-04-01 21:33","pubTimestamp":1743514404,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nFWN3QF13A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GUTS","BK4082"],"gpt_icon":0},{"id":"2524187411","title":"BUZZ-Fractyl Health gains on early data from weight management device trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2524187411","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524187411?lang=en_us&edition=fundamental","pubTime":"2025-04-01 20:17","pubTimestamp":1743509878,"startTime":"0","endTime":"0","summary":"BUZZ-Fractyl Health gains on early data from weight management device trial** Shares of drug developer Fractyl Health GUTS.O rise 6.7% to $1.27 premarket  ** Co says early-stage data shows its weight management device Revita helps maintain weight in patients after they discontinued taking weight-loss drugs ** One month post-procedure, seven patients experienced an average weight regain of just 1.2%, compared with the ~3% typically observed at this time period after GLP-1 discontinuation based on prior clinical studies - GUTS      ** Co expects to announce additional data from the study during Q3 of this year **  Shares of the company have fallen 42.2% YTD ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nL6N3QF0L8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GUTS","BK4082"],"gpt_icon":0},{"id":"2524948851","title":"Fractyl Health Inc - Midpoint Analysis of Remain-1 Pivotal Study Expected in Q3 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2524948851","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524948851?lang=en_us&edition=fundamental","pubTime":"2025-04-01 19:00","pubTimestamp":1743505202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nTUA6JVCDS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GUTS","BK4082"],"gpt_icon":0},{"id":"2524194886","title":"Fractyl Health Inc - Additional Reveal-1 Patient Follow-up Data Expected in Q2 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2524194886","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524194886?lang=en_us&edition=fundamental","pubTime":"2025-04-01 19:00","pubTimestamp":1743505202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nTUA6JVCDS:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GUTS","BK4082"],"gpt_icon":0},{"id":"2524191092","title":"Fractyl Health Reports Positive Early Data Showing Revita® Has Potential to Prevent Weight Regain After Glp-1 Discontinuation","url":"https://stock-news.laohu8.com/highlight/detail?id=2524191092","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524191092?lang=en_us&edition=fundamental","pubTime":"2025-04-01 19:00","pubTimestamp":1743505202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nTUA6JVCDS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","GUTS"],"gpt_icon":0},{"id":"2524001191","title":"Fractyl Health Inc - No Safety or Tolerability Concerns Reported in 15 Patients Treated","url":"https://stock-news.laohu8.com/highlight/detail?id=2524001191","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524001191?lang=en_us&edition=fundamental","pubTime":"2025-04-01 19:00","pubTimestamp":1743505202,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nTUA6JVCDS:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GUTS","BK4082"],"gpt_icon":0},{"id":"2524019416","title":"Fractyl Health Reports Positive Early Data Showing Revita® Has Potential to Prevent Weight Regain After GLP-1 Discontinuation","url":"https://stock-news.laohu8.com/highlight/detail?id=2524019416","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524019416?lang=en_us&edition=fundamental","pubTime":"2025-04-01 19:00","pubTimestamp":1743505200,"startTime":"0","endTime":"0","summary":"New REVEAL-1 study results show early signs of weight maintenance after GLP-1 discontinuation REMAIN-1 pivotal study now more than 50% enrolled; midpoint data analysis anticipated in Q3 2025 BURLINGTO","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/01/3053157/0/en/Fractyl-Health-Reports-Positive-Early-Data-Showing-Revita-Has-Potential-to-Prevent-Weight-Regain-After-GLP-1-Discontinuation.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4144","GUTS","BK4082","BK4590","GLP","IDE"],"gpt_icon":0},{"id":"2517936192","title":"Fractyl Health’s Earnings Call: Progress Amid Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2517936192","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517936192?lang=en_us&edition=fundamental","pubTime":"2025-03-05 08:23","pubTimestamp":1741134237,"startTime":"0","endTime":"0","summary":"Fractyl Health, Inc. (($GUTS)) has held its Q4 earnings call. Read on for the main highlights of the call. Fractyl Health’s recent earnings call pa...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fractyl-healths-earnings-call-progress-amid-challenges?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fractyl-healths-earnings-call-progress-amid-challenges?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRGS","GUTS"],"gpt_icon":0},{"id":"2517060481","title":"Spotlight On Fractyl Health And Two Other Intriguing Penny Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2517060481","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517060481?lang=en_us&edition=fundamental","pubTime":"2025-03-05 01:05","pubTimestamp":1741107908,"startTime":"0","endTime":"0","summary":"As the U.S. stock market grapples with the impact of new tariffs and economic uncertainties, investors are increasingly looking for opportunities beyond well-known names. Penny stocks, a term that might seem outdated, still hold relevance as they often represent smaller or newer companies with potential for growth at lower price points. In this article, we explore three intriguing penny stocks that stand out for their financial strength and offer promising opportunities for those seeking under-the-radar investments.Overview: Fractyl Health, Inc. is a metabolic therapeutics company focused on developing treatments for type 2 diabetes and obesity, with a market cap of $75.03 million.Overview: Quince Therapeutics, Inc. is a biopharmaceutical company dedicated to acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases, with a market cap of $63.80 million.Operations: Quince Therapeutics, Inc. has not reported any revenue segments.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/spotlight-fractyl-health-two-other-170508449.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BABB","QNCX","BK4563","PHX","GPMT","BK4526","BK4509","BK4082","BK4505","BK4110","BK4179","BK4023","BK4213","BK4209","PVL","GUTS","TTI","BK4021","SB"],"gpt_icon":1}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":64,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GUTS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-13","symbol":"GUTS","fiscalQuarterEnding":"2025/03","expectedEps":-0.49,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"post","actualEps":-0.49},{"market":"US","date":"2024-11-12","symbol":"GUTS","fiscalQuarterEnding":"2024/09","expectedEps":-0.5,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":-0.48},{"market":"US","date":"2024-05-13","symbol":"GUTS","fiscalQuarterEnding":"2024/03","expectedEps":-0.3,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715572800000,"reportTimeType":"post","actualEps":-0.75}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GUTS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GUTS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1744948800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GUTS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GUTS","date":"2025-06-20","current":-1.049809,"percent":0.846626,"low":-8.89576,"twenty":-4.300028,"median":-1.995599,"eighty":-1.109173,"high":-0.674617,"avg":-2.60624,"sd":1.710369,"marketCap":93545374},"quantilePoints":[{"date":"2024-02-09","current":-7.199681,"twenty":-7.926572,"median":-7.255064,"eighty":-7.199681,"marketCap":495114890},{"date":"2024-02-16","current":-5.558985,"twenty":-7.340906,"median":-7.07161,"eighty":-5.493911,"marketCap":382285824},{"date":"2024-02-23","current":-5.7459,"twenty":-7.221834,"median":-5.84628,"eighty":-5.558985,"marketCap":395139768},{"date":"2024-03-01","current":-6.230494,"twenty":-7.199681,"median":-5.94666,"eighty":-5.558985,"marketCap":428464809},{"date":"2024-03-08","current":-6.299721,"twenty":-7.091686,"median":-6.265108,"eighty":-5.600521,"marketCap":433225529},{"date":"2024-03-15","current":-4.67287,"twenty":-6.990614,"median":-5.94666,"eighty":-5.398377,"marketCap":321348606},{"date":"2024-03-22","current":-5.039777,"twenty":-6.954615,"median":-5.756284,"eighty":-4.992702,"marketCap":346580423},{"date":"2024-03-28","current":-4.984395,"twenty":-6.796776,"median":-5.655904,"eighty":-5.006548,"marketCap":342771847},{"date":"2024-04-05","current":-4.645542,"twenty":-6.52125,"median":-5.558985,"eighty":-4.724099,"marketCap":358129452},{"date":"2024-04-12","current":-4.260483,"twenty":-6.388333,"median":-5.351301,"eighty":-4.623184,"marketCap":328444925},{"date":"2024-04-19","current":-4.080375,"twenty":-6.308029,"median":-5.233615,"eighty":-4.529956,"marketCap":314560227},{"date":"2024-04-26","current":-4.173535,"twenty":-6.27203,"median":-5.126311,"eighty":-4.286983,"marketCap":321741967},{"date":"2024-05-03","current":-4.043112,"twenty":-6.230494,"median":-4.984395,"eighty":-4.190924,"marketCap":311687531},{"date":"2024-05-10","current":-3.863004,"twenty":-6.11696,"median":-4.746967,"eighty":-4.142482,"marketCap":297802833},{"date":"2024-05-17","current":-4.677292,"twenty":-5.874663,"median":-4.707484,"eighty":-4.142482,"marketCap":320305619},{"date":"2024-05-24","current":-5.285549,"twenty":-5.766668,"median":-4.811037,"eighty":-4.161114,"marketCap":361959713},{"date":"2024-05-31","current":-4.700095,"twenty":-5.762514,"median":-4.746967,"eighty":-4.163598,"marketCap":321867221},{"date":"2024-06-07","current":-4.52524,"twenty":-5.733439,"median":-4.74206,"eighty":-4.176019,"marketCap":309892994},{"date":"2024-06-14","current":-4.14056,"twenty":-5.683595,"median":-4.714084,"eighty":-4.173535,"marketCap":283549695},{"date":"2024-06-21","current":-3.748885,"twenty":-5.639289,"median":-4.700095,"eighty":-4.13846,"marketCap":256727426},{"date":"2024-06-28","current":-3.098426,"twenty":-5.614367,"median":-4.679113,"eighty":-4.13216,"marketCap":212183302},{"date":"2024-07-05","current":-3.126403,"twenty":-5.558985,"median":-4.67287,"eighty":-4.067954,"marketCap":214099178},{"date":"2024-07-12","current":-3.273281,"twenty":-5.558985,"median":-4.618315,"eighty":-4.043112,"marketCap":224157529},{"date":"2024-07-15","current":-3.203339,"twenty":-5.545139,"median":-4.608278,"eighty":-4.043112,"marketCap":219367838},{"date":"2024-08-02","current":-1.909414,"twenty":-5.531294,"median":-4.604496,"eighty":-3.987217,"marketCap":130758558},{"date":"2024-08-09","current":-1.272942,"twenty":-5.44822,"median":-4.571014,"eighty":-3.880394,"marketCap":87172372},{"date":"2024-08-16","current":-2.030155,"twenty":-5.362548,"median":-4.535732,"eighty":-3.763178,"marketCap":112628952},{"date":"2024-08-23","current":-2.513937,"twenty":-5.323174,"median":-4.395959,"eighty":-3.157177,"marketCap":139468192},{"date":"2024-08-30","current":-3.092747,"twenty":-5.304232,"median":-4.330871,"eighty":-3.111015,"marketCap":171579426},{"date":"2024-09-06","current":-2.833578,"twenty":-5.2807,"median":-4.287438,"eighty":-3.037457,"marketCap":157201261},{"date":"2024-09-13","current":-2.470742,"twenty":-5.255768,"median":-4.264795,"eighty":-3.016296,"marketCap":137071832},{"date":"2024-09-20","current":-2.349797,"twenty":-5.230425,"median":-4.220114,"eighty":-2.883684,"marketCap":130362022},{"date":"2024-09-27","current":-2.185656,"twenty":-5.202856,"median":-4.173535,"eighty":-2.641793,"marketCap":121255851},{"date":"2024-10-04","current":-1.995599,"twenty":-5.14085,"median":-4.150837,"eighty":-2.522576,"marketCap":110711864},{"date":"2024-10-11","current":-2.038794,"twenty":-5.128388,"median":-4.12385,"eighty":-2.410269,"marketCap":113108225},{"date":"2024-10-18","current":-2.151101,"twenty":-5.116238,"median":-4.067954,"eighty":-2.30833,"marketCap":119338762},{"date":"2024-10-25","current":-2.168379,"twenty":-5.079786,"median":-4.043112,"eighty":-2.220212,"marketCap":120297307},{"date":"2024-10-31","current":-2.894051,"twenty":-5.039777,"median":-4.043112,"eighty":-2.211573,"marketCap":160556166},{"date":"2024-11-08","current":-2.081989,"twenty":-4.998899,"median":-3.941127,"eighty":-2.185656,"marketCap":115504585},{"date":"2024-11-15","current":-1.598099,"twenty":-4.984395,"median":-3.863004,"eighty":-2.15542,"marketCap":100526792},{"date":"2024-11-22","current":-1.575159,"twenty":-4.935976,"median":-3.777242,"eighty":-2.133823,"marketCap":99083824},{"date":"2024-11-29","current":-1.95748,"twenty":-4.924867,"median":-3.755879,"eighty":-2.090628,"marketCap":123133296},{"date":"2024-12-06","current":-1.636331,"twenty":-4.88286,"median":-3.203339,"eighty":-2.064711,"marketCap":102931740},{"date":"2024-12-13","current":-1.686032,"twenty":-4.835403,"median":-3.126403,"eighty":-2.038794,"marketCap":106058171},{"date":"2024-12-20","current":-1.391646,"twenty":-4.764415,"median":-3.10542,"eighty":-1.995599,"marketCap":87540078},{"date":"2024-12-27","current":-1.575159,"twenty":-4.746556,"median":-3.092747,"eighty":-1.97958,"marketCap":99083824},{"date":"2025-01-03","current":-1.628684,"twenty":-4.743771,"median":-3.023635,"eighty":-1.95748,"marketCap":102450750},{"date":"2025-01-10","current":-1.452817,"twenty":-4.739262,"median":-3.02149,"eighty":-1.912585,"marketCap":91387993},{"date":"2025-01-17","current":-1.383999,"twenty":-4.725274,"median":-2.961882,"eighty":-1.793847,"marketCap":87059088},{"date":"2025-01-24","current":-1.567513,"twenty":-4.714084,"median":-2.915648,"eighty":-1.74338,"marketCap":98602835},{"date":"2025-01-31","current":-1.483403,"twenty":-4.707484,"median":-2.876773,"eighty":-1.674563,"marketCap":93311951},{"date":"2025-02-07","current":-1.231071,"twenty":-4.700095,"median":-2.751508,"eighty":-1.628684,"marketCap":77439299},{"date":"2025-02-14","current":-1.269303,"twenty":-4.679113,"median":-2.600327,"eighty":-1.598099,"marketCap":79844247},{"date":"2025-02-21","current":-1.116375,"twenty":-4.677656,"median":-2.557132,"eighty":-1.575159,"marketCap":70224458},{"date":"2025-02-28","current":-1.116375,"twenty":-4.673754,"median":-2.479381,"eighty":-1.574866,"marketCap":70224458},{"date":"2025-03-07","current":-1.118071,"twenty":-4.651008,"median":-2.410269,"eighty":-1.558338,"marketCap":76804746},{"date":"2025-03-14","current":-0.858137,"twenty":-4.63179,"median":-2.367075,"eighty":-1.536928,"marketCap":58948866},{"date":"2025-03-21","current":-0.875941,"twenty":-4.612293,"median":-2.315241,"eighty":-1.500225,"marketCap":60171871},{"date":"2025-03-28","current":-0.897305,"twenty":-4.602227,"median":-2.276365,"eighty":-1.465051,"marketCap":61639478},{"date":"2025-04-04","current":-0.811847,"twenty":-4.596288,"median":-2.211573,"eighty":-1.424369,"marketCap":55769051},{"date":"2025-04-11","current":-0.674617,"twenty":-4.575848,"median":-2.189976,"eighty":-1.390881,"marketCap":46342125},{"date":"2025-04-17","current":-0.790483,"twenty":-4.567288,"median":-2.177017,"eighty":-1.373294,"marketCap":54301445},{"date":"2025-04-25","current":-0.911548,"twenty":-4.553655,"median":-2.15542,"eighty":-1.28911,"marketCap":62617882},{"date":"2025-05-02","current":-0.904427,"twenty":-4.533633,"median":-2.142462,"eighty":-1.239408,"marketCap":62128680},{"date":"2025-05-09","current":-1.176397,"twenty":-4.51413,"median":-2.125184,"eighty":-1.175327,"marketCap":80811449},{"date":"2025-05-16","current":-0.906903,"twenty":-4.440265,"median":-2.090628,"eighty":-1.159286,"marketCap":80811449},{"date":"2025-05-23","current":-0.964616,"twenty":-4.366843,"median":-2.07335,"eighty":-1.14827,"marketCap":85953996},{"date":"2025-05-30","current":-1.044313,"twenty":-4.342464,"median":-2.064711,"eighty":-1.127782,"marketCap":93055608},{"date":"2025-06-06","current":-1.066299,"twenty":-4.331699,"median":-2.043114,"eighty":-1.113119,"marketCap":95014673},{"date":"2025-06-13","current":-1.192715,"twenty":-4.319408,"median":-2.030155,"eighty":-1.113119,"marketCap":106279300},{"date":"2025-06-20","current":-1.049809,"twenty":-4.300028,"median":-1.995599,"eighty":-1.109173,"marketCap":93545374}],"updateTime":1750728637170}}}